HCG posts revenue worth Rs 2,579 million in Q4 In FY 19, the company's revenue is at Rs 9,787 million
Strand Life Sciences publish study on utility of germline cancer multi-gene test for hereditary… As part of this study, 141 unrelated patients and families with breast or ovarian cancer were tested for mutations in 13 genes…
Genetic testing can help in choosing the right drug and the right dose for a patient Dr Vijay Chandru, Chairman and CEO, Strand Life Sciences, gives a rundown on the genetic diagnostics market in India, its future…
Strand Life Sciences names Scott Storrer as Global President, introduces US management team US team focused on National Launch of StrandAdvantage - company’s pan-cancer genomic profiling service
Strand Life Sciences names Scott Storrer as Global President, introduces US management team US team focused on National Launch of StrandAdvantage, company’s pan-cancer genomic profiling service